NewcelX Ltd. is projected to rise to $4.47 by 2027, a +31% move from its current price of $3.42. NCEL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.32 | $3.42 | $3.53 | +0.02% |
| Aug 6 | $3.27 | $3.42 | $3.57 | +0.03% |
| Aug 7 | $3.24 | $3.42 | $3.61 | +0.05% |
| Aug 8 | $3.22 | $3.42 | $3.64 | +0.06% |
| Aug 9 | $3.19 | $3.42 | $3.67 | +0.08% |
| Aug 10 | $3.17 | $3.42 | $3.69 | +0.09% |
| Aug 11 | $3.15 | $3.42 | $3.72 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.15 | $3.42 | $3.72 | +0.11% |
| Week 2 | $3.05 | $3.43 | $3.85 | +0.21% |
| Week 3 | $2.98 | $3.43 | $3.96 | +0.32% |
| Week 4 | $2.91 | $3.43 | $4.05 | +0.42% |
| Week 5 | $2.86 | $3.44 | $4.13 | +0.53% |
| Week 6 | $2.81 | $3.44 | $4.21 | +0.64% |
| Week 7 | $2.77 | $3.45 | $4.28 | +0.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NewcelX Ltd. is a biopharmaceutical company focused on developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications.
It also develops DOXA, a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd.
was founded in 2008 and is headquartered in Kloten, Switzerland.
NewcelX Ltd. trades in Healthcare under the NCEL symbol and is currently priced at $3.36. Its market capitalization is $18.1M and it ranks 4627 by market cap.
A major floor 45.0% below — a decisive break under it would weaken the trend.
The nearest floor, 3.2% below — buyers have tended to step in here.
The nearest ceiling, 23.7% above — a clean break opens room to run.
A major ceiling 43.6% above — clearing it would confirm fresh momentum.
Key NCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.49 | Sell | $3.51 | Sell |
| MA 10 | $3.64 | Sell | $3.61 | Sell |
| MA 20 | $3.84 | Sell | $3.69 | Sell |
| MA 50 | $3.56 | Sell | $3.59 | Sell |
| MA 100 | $3.24 | Buy | $3.78 | Sell |
| MA 200 | $3.86 | Sell | $6.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.38 | Neutral |
| Stoch RSI (14) | 20.61 | Neutral |
| CCI (20) | -111.34 | Sell |
| Williams %R (14) | -82.30 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -11.20 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 17.70 | Buy |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -0.21 | Sell |
| Ultimate (7,14,28) | 39.44 | Neutral |
| Momentum (10) | -0.60 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 3.37 | Buy |
| ADX (14) | 16.88 | Neutral |
| ATR (14) | 0.11 | Info |
The near-term technical picture is BEARISH. RSI14 is 40, with SMA50 at $3.55 and SMA200 at $3.93. Near-term support sits at $3.15 and resistance at $4.23. The 30-day price range spans from $2.75 to $4.11.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.88 | $3.42 | $4.72 | 0% | Neutral | |
| $3.52 | $4.47 | $6.02 | +31% | Bullish | |
| $3.43 | $4.49 | $6.32 | +31% | Bullish | |
| $3.53 | $4.75 | $6.90 | +39% | Bullish | |
| $3.46 | $4.78 | $7.13 | +40% | Bullish | |
| $3.15 | $4.44 | $6.78 | +30% | Bullish | |
| $3.43 | $4.93 | $7.70 | +44% | Bullish | |
| $3.84 | $5.64 | $8.96 | +65% | Bullish | |
| $4.30 | $6.42 | $10.40 | +88% | Bullish | |
| $4.61 | $7.01 | $11.54 | +105% | Bullish | |
| $5.39 | $8.87 | $15.62 | +159% | Bullish | |
| $7.33 | $13.88 | $26.96 | +306% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.88 | $3.42 | $4.26 | +0.00% |
| September 2026 | $2.98 | $3.53 | $4.32 | +3.34% |
| October 2026 | $2.90 | $3.47 | $4.29 | -1.89% |
| November 2026 | $2.99 | $3.60 | $4.50 | +3.75% |
| December 2026 | $3.09 | $3.74 | $4.72 | +4.10% |
Click any year to see its month-by-month NCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NCEL to range from $1.88 to $4.72 through 2026. The $3.42 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NCEL price prediction for 2027 points to an average of $4.47 (low $3.52, high $6.02) — a potential gain of +31% on today's $3.42. Momentum favours further upside here.
In 2028, NCEL is projected to trade between $3.43 and $6.32, averaging $4.49 — a potential gain of +31% from today's $3.42. That is up +1% on the projected 2027 average. Buyers look set to stay in control over this stretch.
NewcelX Ltd.'s 2029 outlook centres on $4.75, within a $3.53 to $6.90 range. That is up +6% on the projected 2028 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2030, NCEL could reach as high as $7.13, with a base case around $4.78 and support toward $3.46 — roughly +40% from $3.42. Buyers look set to stay in control over this stretch.
Expect NCEL to range from $3.15 to $6.78 through 2031. The $4.44 average target implies a +30% move from current prices. That is -7% versus the projected 2030 average. Momentum favours further upside here.
The NCEL price prediction for 2032 points to an average of $4.93 (low $3.43, high $7.70) — a potential gain of +44% on today's $3.42. Buyers look set to stay in control over this stretch.
In 2033, NCEL is projected to trade between $3.84 and $8.96, averaging $5.64 — a potential gain of +65% from today's $3.42. That is up +14% on the projected 2032 average. Momentum favours further upside here.
NewcelX Ltd.'s 2034 outlook centres on $6.42, within a $4.30 to $10.40 range. That is up +14% on the projected 2033 average. That marks a +88% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NCEL could reach as high as $11.54, with a base case around $7.01 and support toward $4.61 — roughly +105% from $3.42. Momentum favours further upside here.
Expect NCEL to range from $5.39 to $15.62 through 2040. The $8.87 average target implies a +159% move from current prices. That is up +26% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NCEL price prediction for 2050 points to an average of $13.88 (low $7.33, high $26.96) — a potential gain of +306% on today's $3.42. Momentum favours further upside here.
Investing $1,000 in NCEL today (≈ 292.397661 NCEL) could be worth
$4,059.84
+$3,059.84 (+306%) by 2050 · US Dollar
Based on the average projected NCEL price of $13.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NCELwould be worth at today's price.
$1,000 invested in NCEL on Jul 31, 2025 (≈ 54.347827 NCEL) would be worth
$185.87
-$814.13 (-81.4%) today · 0.19× · US Dollar
Based on a NCEL entry price of $18.4 vs. today's $3.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.76 | $910.79 | -8.9% |
| 1 month ago | $3.85 | $888.31 | -11.2% |
| 3 months ago | $3.85 | $888.31 | -11.2% |
| 6 months ago | $2.75 | $1,243.64 | +24.4% |
| 1 year ago | $18.4 | $185.87 | -81.4% |
| All time (5.0y) ago | $1,024 | $3.34 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NCEL forecast.
Our base-case forecast reaches $6.80 around 2035.
Implied market cap at $6.80: $36.61M
From 2026 onward the forecast shows a bullish trajectory. In 2026 the average price is $3.36 with neutral sentiment. From 2027 onward, the forecast remains bullish, with 2027 average $4.39 and max $5.91 (ROI 30.5), 2028 average $4.46 (ROI 32.6), 2029 average $4.69 (ROI 39.6), and 2030 average $4.72 (ROI 40.5).
The trajectory continues with 2031 $4.44, 2032 $4.93, 2033 $5.66, 2034 $6.46, 2035 $6.99, 2040 $8.99, and 2050 $14.00, with ROIs of 32, 46.5, 68.5, 92.1, 108, 167.6, and 316.6 respectively. These are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
Avg $4.72, min $3.43, max $7.03, ROI 40.5, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with 2027 avg $4.39 and max $5.91; 2028 avg $4.46; 2029 avg $4.69; 2030 avg $4.72.
Yes—the 2027 max is $5.91, indicating it could exceed $5 within the forecast horizon.
Current price is $3.36; Market cap is $18.1M.
Bearish sentiment; RSI14 40; SMA50 $3.55; SMA200 $3.93; Support $3.15; Resistance $4.23; 30-day range $2.75-$4.11.
NewcelX Ltd. Community Discussion
0Share your NewcelX Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.